Downloads: 11
Research Paper | Ophthalmology | Volume 15 Issue 5, May 2026 | Pages: 921 - 926 | Cambodia
Visual and Anatomical Outcomes of Intravitreal Bevacizumab for Diabetic Macular Edema at Preah Ang Duong Hospital
Abstract: Purpose: This study was conducted to evaluate the visual outcomes of intravitreal Bevacizumab in patients with diabetic macular edema (DME) treated at Preah Ang Duong Hospital. The primary outcome measure was improvement in best-corrected visual acuity (BCVA), while secondary outcomes included reduction in central macular thickness (CMT), intraocular pressure (IOP) changes, treatment safety, and sustainability of visual improvement during follow-up. Methods: This was a prospective hospital-based study involving 97 patients with diabetic macular edema who received monthly intravitreal Bevacizumab injections at Preah Ang Duong Hospital, Phnom Penh, Cambodia. Baseline and follow-up assessments included socio-demographic characteristics, systemic comorbidities, BCVA, CMT measured by optical coherence tomography, IOP, and adverse events. Data were entered using EpiData and imported into SPSS version 25 for statistical analysis. Descriptive statistics were presented as mean, standard deviation, frequency, and percentage. Baseline and follow-up outcomes were compared using paired t-test and repeated-measures ANOVA, with a p-value
Keywords: Diabetic Macular Edema, Bevacizumab, Intravitreal Anti-VEGF, Optical Coherence Tomography, Visual Acuity, Cambodia
How to Cite?: Vong Virak Ou, Leng Un, Lykheang Lou, Ratneary Hav, Saly Saint, Piseth Kong, "Visual and Anatomical Outcomes of Intravitreal Bevacizumab for Diabetic Macular Edema at Preah Ang Duong Hospital", Volume 15 Issue 5, May 2026, International Journal of Science and Research (IJSR), Pages: 921-926, https://www.ijsr.net/getabstract.php?paperid=SR26512161251, DOI: https://dx.doi.org/10.21275/SR26512161251